Guilbault Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$242K Sell
1,533
-86
-5% -$13.6K 0.24% 69
2026
Q2
$256K Buy
+1,619
New +$219K 0.26% 61

Other funds holding XBI

Guilbault Capital's XBI Position: Q3 2026 in Review

Guilbault Capital reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 5.3% in Q3 2026, selling an estimated $13.6K and leaving 1,533 shares worth $242K. The position accounts for 0.24% of the portfolio, ranked #69.

Guilbault Capital first reported a position in XBI in Q2 2026 and has held it in 2 quarters since. The position peaked at $256K in Q2 2026. 963 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Guilbault Capital held 1,533 shares of State Street SPDR S&P Biotech ETF worth $242K as of Q3 2026.
  • Guilbault Capital sold 86 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $13.6K.
  • State Street SPDR S&P Biotech ETF made up 0.24% of Guilbault Capital's portfolio in Q3 2026, its #69 holding.
  • Guilbault Capital first reported a position in State Street SPDR S&P Biotech ETF in Q2 2026 and has held it in 2 quarters since.
  • Guilbault Capital's State Street SPDR S&P Biotech ETF position peaked at $256K in Q2 2026.
  • 963 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Guilbault Capital's 13F filing for Q3 2026, filed 28 Oct 2026.